NCT05907837 Early Detection & Intervention of Cerebral Palsy in Ireland
| NCT ID | NCT05907837 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University College Cork |
| Condition | Cerebral Palsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2023-07-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2023-07-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cerebral palsy (CP) is the most common lifelong physical disability. It is defined as a non-progressive disorder of movement originating from neural lesions in the perinatal period, and is associated with a wide range of common comorbidities in many individuals. These include problems speaking, hearing, seeing, thinking, feeding and controlling their bladder. People with CP often have additional challenges such as behavioural and emotional issues, pain, and poor sleep. Many of these challenges respond well to intervention in early childhood, as brain plasticity is at its greatest in the first 2 years of life. However, in most clinical settings, the age for diagnosis of CP is between 24 to 29 months, after this window of neurodevelopmental opportunity. This project will aim to improve the Early Detection of Cerebral Palsy in Ireland. This will be achieved by implementing an evidence-based approach to follow-up of High risk infants.
Eligibility Criteria
Inclusion Criteria: * Legal guardians must be able and willing to give written informed consent and to comply with the requirements of this study protocol. * All infants considered high risk for cerebral palsy and neuro-developmental impairment will be eligible, specifically including: * All preterm infants born ≤32 weeks Post Menstrual Age or ≤1500 gm birth weight * All encephalopathic infants * Neurological risk factors (e.g., injury/malformation on neuroimaging, persistently abnormal neurological exam) Exclusion Criteria: * Death prior to discharge from the neonatal unit.
Contact & Investigator
Brian H Walsh
PRINCIPAL INVESTIGATOR
University College Cork
Frequently Asked Questions
Who can join the NCT05907837 clinical trial?
This trial is open to participants of all sexes, up to 40 Weeks, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05907837 currently recruiting?
Yes, NCT05907837 is actively recruiting participants. Contact the research team at brianhenry.walsh@ucc.ie for enrollment information.
Where is the NCT05907837 trial being conducted?
This trial is being conducted at Cork, Ireland, Dublin, Ireland, Dublin, Ireland, Dublin, Ireland and 1 additional location.
Who is sponsoring the NCT05907837 clinical trial?
NCT05907837 is sponsored by University College Cork. The principal investigator is Brian H Walsh at University College Cork. The trial plans to enroll 1,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.